Side-by-side comparison of AI visibility scores, market position, and capabilities
All-in-one digital marketing platform with $350M revenue; keyword research, competitive intelligence, and SEO tools for 1M+ users competing with Ahrefs for marketer mindshare.
Semrush is an all-in-one digital marketing platform providing SEO tools, competitive intelligence, PPC research, social media analytics, and content marketing tools for marketers, SEO professionals, and digital agencies. Listed on NYSE (NYSE: SEMR) and headquartered in Boston, Massachusetts (with major operations in St. Petersburg, Russia), Semrush generates approximately $350 million in annual revenue and serves over 1 million users with a database of 25+ billion keywords and competitive data on 800 million+ domains.\n\nSemrush's core product is its keyword research and competitive analysis engine — entering any domain shows its organic search rankings, estimated traffic, top keywords, and backlink profile, enabling marketers to understand their competitors' SEO strategies. The platform includes position tracking (monitoring keyword rankings over time), site auditing (identifying technical SEO issues), backlink analysis, and content optimization tools. The advertising research module shows competitors' PPC ad history, spending estimates, and landing pages.\n\nIn 2025, Semrush competes in the SEO and digital marketing intelligence market against Ahrefs (the other leading SEO platform), Moz, SpyFu, and Similarweb (traffic analytics). The two dominant platforms — Semrush and Ahrefs — have been engaged in continuous feature expansion as each adds tools beyond core keyword research into broader marketing analytics. Semrush has invested in AI tools for content creation and optimization. The 2025 strategy focuses on Semrush AI (AI writing and content generation tools), expanding into broader digital marketing workflow automation, and growing its enterprise segment with agency and brand team subscriptions.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.